The Armchair Analyst
Login
Subscribe
The Armchair Analyst
Level up your knowledge on ASX life sciences companies.
10 hours ago
The Moment Invion (IVX) Became “Investible” for me
Jason Segal
Dec 03, 2025
The Hidden Signals Found in AGM Updates
Jason Segal
Dec 02, 2025
Inside the Visionflex Lazarus Story
Jason Segal
Dec 01, 2025
What happens when a biotech stock goes up on "no news"...
Jason Segal
Nov 28, 2025
Biotech green shoots emerge in Australia and the US
Jason Segal
Nov 27, 2025
What does a "leveraged" clinical trial bet look like
Jason Segal
Nov 26, 2025
Paul Hopper voted out, PIQ gets Reimbursement, Ethics Approval for RAC
Jason Segal
Nov 25, 2025
Philips swings big at ASX listed minnows
Jason Segal
Nov 24, 2025
Monash IVF says "No", Final Patient in Phase 3 and a 99.50% Result
Jason Segal
